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ABSTRACT:

M

Objective. The Consolidated Standards of Reporting Trials (CONSORT) recommends

D

reporting adverse events (AEs) and dropouts (DOs) with their definitions. The purpose

TE

of this study was to identify how AEs and DOs were reported in randomized controlled
trials (RCTs) of therapeutic exercise for knee osteoarthritis (OA).

EC

Methods. Data sources were the Cochrane Library, EMBASE, PUBMED, and CINAHL.

CO
RR

Databases were searched to identify RCTs of therapeutic exercise for Knee OA
published from January 1, 1980, through July 23, 2020. Researchers independently
extracted participant and intervention characteristics and determined whether a clear
statement of and reasons for AEs and DOs existed. The primary outcome was exercise-

N

related harm. Physiotherapy Evidence Database (PEDro) scoring described study

U

quality and risk of bias. Descriptive and inferential statistics characterized results. Metaanalysis was not performed due to data heterogeneity.
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Results. One hundred 13 studies (152 arms) from 25 countries were included with 5909
participants exercising. PEDro scores ranged from 4 to 9. Exercise intensity was not
specified in 57.9% of exercise arms. Fifty studies (44.2%) included an AE statement

RI
PT

had a DO statement. Sixteen studies (15.5%) provided reasons for DOs that could be

SC

classified as AEs among 39 patients, yielding a 13.1% increase in AEs. Thus, 336
patients (6.0%) experienced exercise-related harm among studies with a clear

AN

pre– and post–CONSORT 2010 (12.2% vs 3.1%; X21=21.2).

U

statement of AEs and DOs. A significant difference existed in misclassification of DOs

Conclusions. In some studies, the reason for DOs could be considered AEs, leading to

M

potential underreporting of harm. Improvements in reporting of harm were found pre–

D

and post–CONSORT 2010. Greater clarity regarding AE and DO definitions and TherEx

TE

intensity are needed to determine safe dosing and mode of therapeutic exercise for knee
OA.

EC

Impact. More adherence to the CONSORT statement is needed regarding reporting of

CO
RR

and defining AEs, DOs, and therapeutic exercise intensity; however, despite this,
therapeutic exercise seems to be associated with minimal risk of harm.

U

N

Introduction

Therapeutic exercise is a major component of the conservative management of knee

osteoarthritis (OA).1-3 Evidence suggests that the mechanical loading associated with exercise
can reduce inflammation and cartilage degradation,4 improve physical function, muscle strength
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and 24 (21.2%) reported AEs, yielding 297 patients. One hundred three studies (91.2%)

and reduce joint pain.5-7 Therapeutic exercise is the “systematic performance or execution of
planned physical movements or activities intended to remediate or prevent impairments of body
functions and structures, enhance activities and participation, reduce risk, optimize overall

RI
PT

information regarding the intensity, frequency, duration, and mode of exercise along with the

SC

type of supervision used to ensure proper dosing and technique. Without a complete description
of therapeutic exercise interventions in clinical trials, clinicians and patients cannot reliably

U

implement therapeutic exercises shown to be effective, and researchers cannot replicate findings

AN

or extend the research in this area.9

While therapeutic exercise is perceived as a less risky intervention for managing knee

M

OA symptoms in comparison to invasive interventions such as surgery and NSAIDs, it does

D

require active participation by the patient and substantial time commitment. The potential exists

TE

for exercise to lead to increased knee pain or exercise-related injury (eg, falls).10-12 Thus, it is
important for patients to receive detailed instruction in the prescription of therapeutic exercise

EC

from physical therapists or other appropriate health professionals. In this process, patients should

CO
RR

be informed about exercise-related symptoms (eg, temporary muscle discomfort) that are to be
expected and not harmful, and the potential for and the incidence of risk for exercise-related
adverse events. Disclosure of harm from therapeutic exercise is also a necessary component of
informed consent in clinical trials of therapeutic exercise.

N

The CONSORT statement for reporting clinical trials13 is a universally accepted method

U

for enhancing the consistency of reporting components of and problems with clinical trials.14
Originally published in 1996,15 the CONSORT statement has been updated three times13, 15, 16
with the most recent version being published in 2010.13 In 2004, CONSORT published a
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health, and enhance fitness and well-being”.8 Prescription of therapeutic exercise includes

statement specifically addressing the reporting of harm.17 This statement specifies that adverse
events and dropouts should be reported separately along with their corresponding reasons and
that adverse events should be classified by severity.

RI
PT

indirectly from the assigned treatment.18 More recently the PRISMA Harms checklist provides
guidance on how systematic reviews should address the reporting on harms.19 The PRISMA

SC

Harms group created a new term, “adverse effects” which is defined as “an unfavorable outcome

U

that occurs during or after the use of a drug or other intervention but is not necessarily caused by

AN

it.” Adverse effects become adverse events when the causality of the unfavorable outcome can
potentially be attributed to the intervention. Finally, study-related harm is considered to be the

M

totality of adverse consequences occurring during or after an intervention.19

D

Patient withdrawal (or dropout) from studies due to harm-related reasons can occur, but

TE

dropouts can also occur and not be associated with harm attributed to the intervention.
Understanding why patients decide not to continue in a study is important to determine whether

EC

the intervention has any harmful impact, as their reasons for dropping out could indicate their

CO
RR

inability to tolerate the intervention.17 Thus, clear definitions of both dropouts (DOs) and AEs
are needed. However, there is little guidance regarding how to define and categorize AEs and
DOs in therapeutic exercise trials20 and this lack of consistency may lead to overlap in reasons
for AEs and DOs. As such, it is difficult to ascertain the risk of harm in therapeutic exercise as

N

well as the most effective dosage, intensity, and mode of therapeutic exercise for patients with

U

knee OA.
Exercise-related harm has been investigated in a number of systematic reviews11, 21-25 but

each review operationalized harm differently and assessed exercise-related harm in different
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Adverse events (AEs) are defined as any negative outcome resulting either directly or

populations. For example, Sherrington examined whether exercise performed by older adults
reduced their risk of falls.12 Neimeijer et al, examined whether exercise therapy among adult
patients, regardless of health condition, led to a 1.19 increased risk of non-serious AEs.11 None
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PT

in clinical trials within rheumatic diseases, Ethgen et al (2005) compared pharmacologic trials to
nonpharmacologic trials and found pharmacologic trials were 5.2 times more likely to discuss

SC

harms than non-pharmacologic trials.18 Additionally, Quicke et al. performed a systematic

U

review of physical activity interventions in adults aged 45 years and older with knee pain to

primarily low intensity physical activity interventions.22

AN

examine safety-related outcomes and found no serious safety issues in studies which used

M

This study aimed to identify how AEs and DOs are defined in randomized controlled

D

trials of therapeutic exercise among adults with knee OA and whether statements of AEs and

TE

DOs were included in manuscripts, in order to better describe the frequency and severity of
therapeutic exercise-related harm, as recommended in the CONSORT Harms statement.17

EC

Additionally, this study aimed to characterize the attributes of the study populations and

CO
RR

therapeutic exercise interventions and to ascertain the incidence rate of therapeutic exercise
related harm in these studies. We hypothesized that the classification of AEs and DOs would be
inconsistent across studies and that studies published prior to the CONSORT-2010 consensus
statement13 would be less likely to mention AEs and consistently define AEs and DOs than

N

studies published after this statement. Based on our findings, we provide recommendations for

U

documenting exercise intervention details and the use of operational definitions of DOs and AEs
along with methods for reporting these in clinical trials of therapeutic exercise. We also discuss
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of these studies specifically addressed AEs in adults with arthritis. In a review of harm reporting

how our recommendations align with or add to the current CONSORT13 and CONSORT
Harms17 reporting guidelines.
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[H2] Data Sources and Searches

Four researchers (MDI, JvH, SC, JB) used the American Physical Therapy Association’s

SC

definition of therapeutic exercise8 to conduct a systematic review of randomized controlled trials

U

of therapeutic exercise for managing knee OA symptoms. We searched the Cochrane Library,

AN

CINAHL, PUBMED, and EMBASE databases for peer reviewed randomized controlled trials
conducted in adults diagnosed with knee OA and published in English between January 1, 1980

M

and July 23, 2020 using the following search terms: (knee osteoarthritis OR knee arthritis) AND

D

(exercise OR exercise therapy OR strengthening OR aerobics OR anaerobic OR dynamic

TE

exercise OR isotonic OR isometric OR isokinetic OR physical therapy). These particular search
terms were used in an effort to include every relevant type of therapeutic exercise. Studies which

EC

compared non-pharmacologic interventions to therapeutic exercise were eligible as long as the

CO
RR

therapeutic exercise intervention arm included only therapeutic exercise. As we used the APTA
definition of therapeutic exercise,8 exercise was broadly defined and could include Tai Chi, yoga,
strengthening, flexibility, aerobic [on land or in water], balance or agility training etc. We
excluded studies which (1) enrolled patients with non-specified knee pain, (2) studies which

N

enrolled patients with other forms of arthritis (hip OA, rheumatoid arthritis, etc.) and which did

U

not separately report patient outcomes by diagnosis (either primary outcomes or for DOs and
AEs) and (3) studies of unsupervised exercise or studies where the level of supervision was
unspecified. We used the PRISMA harms guidelines19 for the development and reporting of this
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[H1]Methods

systematic review (Suppl. Appendix 1). This systematic review was registered with and
approved by PROSPERO, the international prospective register of systematic reviews.26

RI
PT

Four researchers (MDI, JvH, SC, JB) individually screened 4,649 titles and 386 abstracts

SC

for eligibility and eliminated studies which did not meet the inclusion criteria. In instances where
article eligibility was unclear, the researchers discussed the rationale for inclusion and after

U

deliberating, came to a consensus about whether or not the study met inclusion/exclusion criteria.

AN

Figure 1 provides the flowchart portraying the process of study elimination. Two hundred thirtyfour full text articles were screened for eligibility and the article reference lists were examined

M

for eligible studies. Prior to the final data analysis, the search was re-run to determine whether

D

any relevant studies had been missed.

TE

[H2] Data Extraction and Quality Assessment

The research team (JvH, MDI, SC, JB, KJ) extracted data from final 113 studies (Suppl.

EC

Appendix 2 and 3) according to predefined criteria, using a standardized form. This form

CO
RR

included the following data elements: year of publication, country where study was conducted,
total number of subjects in exercise arm(s), program length, exercise intensity and how intensity
was assessed (eg, BORG scale, 70% of one repetition max), frequency and mode of exercise, and
duration of exercise sessions, the amount of exercise supervision, whether there was a clear

N

statement of AEs, the number and type of AEs (related to therapeutic exercise and not related to

U

therapeutic exercise), whether there was a clear statement of DOs, the number of DOs and
reasons for DOs. The results section of each article was thoroughly annotated to ensure that a
definition of AEs associated with therapeutic exercise was clearly reported in the narrative
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[H2] Study Selection

tables, or figures and not overlooked. In instances where a DO could be considered an AE or an
adverse effect, we recorded that outcome as harm.
We used the first assessment after the exercise intervention as the primary endpoint for

RI
PT

assessment, rather, they reported these outcomes at the first assessment period post-exercise
intervention and then summarized the outcomes across all evaluation timepoints.

SC

The PEDro scoring method27 was used to independently rate the internal validity of the

U

studies and identify risk of bias. Specific data elements examined included: eligibility, random

AN

allocation, concealed allocation, baseline comparability, subject blinded, therapist blinded to
allocation, assessor blinded to allocation, measures of key outcomes, intention to treat, results

M

comparison, and point estimate of variability. One point was given to each item, except for study

D

eligibility criteria, which is not included in the PEDro score. These points were then summed to

TE

create a single score for each article ranging from 0 to 10.27 When disagreements occurred
between the raters regarding the PEDro scoring, the researchers discussed and make to a

EC

consensus regarding the scoring attributed to the articles (Suppl. Appendix 4).

CO
RR

[H2] Data Synthesis and Analysis

We conducted both a qualitative and quantitative synthesis of the studies. A meta-

analysis was not conducted due to study heterogeneity and the focus on counts of outcomes
versus intervention effect sizes.28 To evaluate therapeutic exercise data, data were grouped into

N

categories of exercise modes (strengthening, aerobic etc.), frequency per week, and session

U

durations (eg, unspecified, 1-2x per week, etc.). In cases where a range of values was provided
for any of these variables, the average was calculated, or the number was rounded up to the next
category. Next, the percent of studies using various modes of exercise, along with exercise
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the collection of AEs and DOs. Many studies did not record AEs and DOs at each follow-up

intensity level, and how intensity was assessed, duration, and frequency was calculated. We
stratified studies based on the timeframe of the publication of the CONSORT-2010 statement
using a cut point of 2011 (eg, by pre-CONSORT-2010 statement and post CONSORT-2010

RI
PT

We calculated the percent of AEs and DOs occurring among the group of individuals

SC

exercising within each study or each study arm (when more than one exercise program was being
tested). In studies where it was difficult to ascertain the reasons for DOs due to data being

U

reported across intervention groups and during the follow-up periods when no therapeutic

AN

exercise was provided, we coded those data as unspecified reasons for DOs. We documented all
reasons for DOs and specifically identified when the reason for dropping out of a study was an

M

exercise-related harm (ie, DOs that met the definition of an AE were reclassified as AEs). For

D

example, if exercise-related knee pain was given as a reason for someone refusing to continue in

TE

the study, then the DO was reclassified as an AE. Additionally, AEs and newly reclassified DOs
were categorized by severity using the following operational definition: severe (fracture,

CO
RR

to exercise program).29

EC

permanent damage, disability or death) and non-serious (muscle strain, soreness, fall not related

Chi squared tests were used to determine whether differences existed regarding a clear

statement of AEs (Y/N) and DOs (Y/N) and regarding the misclassification of dropouts, pre- and
post-publication of the CONSORT-2010 statement.13 Finally, we examined the incidence rate

N

(IR) of non-serious and severe AEs plus exercise-related DOs, along with their 95% confidence

U

intervals (95% CIs). To accomplish this, we calculated exposure time (n = 224,480 person hours
of exercise) as the duration of exercise sessions (minutes) x frequency of sessions per week x
length of exercise program (number of weeks) among studies which included these data. Forty-
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statement publication).13

seven (30.9%) study arms with unspecified total weeks of exercise training or/and unspecified
frequency per week or/and unspecified duration of individual exercise sessions were excluded
from the incidence rate calculation. The statistical significance level for all tests was defined as a

RI
PT

SC

IL).

[H2] Role of the funding source

AN

U

The funders played no role in the design, conduct, or reporting of this study.

[H2] Study Characteristics and Study Quality

M

[H1] Results

D

Of the included 113 studies conducted in 25 countries, 54 (47.8%) were published from

TE

countries in North America and Western Europe. These studies included 152 exercise arms,
yielding 5,909 subjects exercising. The median number of patients per therapeutic exercise arm

EC

was 28 (range 8 - 209) (Suppl. Appendix 2). The PEDro scores of these studies ranged from 4 to

CO
RR

9. There were two studies30, 31 that had a PEDro score of 4. With respect to risk of bias, subject
blinding was performed in 15 (13.3%) of studies and assessors were blinded in 79 studies
(69.9%) (Suppl. Appendix 4).

[H2] Attributes of Therapeutic Exercise

N

Thirty-eight studies included more than one exercise arm within the study (Suppl.

U

Appendix 3). Most exercise interventions were prescribed for a period of six and up to twelve
weeks (32.9%) and the most common frequency examined was three times per week (52.6%). In
61.2% of exercise arms, the duration of each exercise session was 30 minutes up to and including
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p value of 0.05. Data analysis were conducted using SPSS for Mac 25.0 (SPSS Inc., Chicago,

60 minutes. Of the 152 supervised exercise arms, 112 were supervised throughout the program.
Strengthening exercise, whether progressive strengthening or not, was the most common mode
of exercise (30.3%), followed by various combinations of exercise modes. The assessment of

RI
PT

which specified exercise intensity and had reported AEs, we were not able to determine whether

SC

exercise intensity was a causative factor for AEs (Tab. 1).

U

[H2] Reporting of Adverse Events

AN

Fifty studies (44.2%) included a statement of AEs, and 24 studies (21.2%) reported
exercise-related AEs, for a total of 297 AEs (Tab. 2). While the proportion of studies which

M

included a statement of AEs increased pre- and post-CONSORT-201013 (37.2% versus 48.6%),

D

this difference was not statistically significant (X21 = 1.4; p= .24). We found no established

TE

definition of the severity of AEs nor classification of AEs by severity in many of these
randomized controlled trials of therapeutic exercise. The following symptoms were recorded as

EC

AEs within the 113 studies: dizziness, back pain, hip pain, knee pain, falls/fractures, and

CO
RR

“unspecified” injury during strength training. Among the 50 studies with a statement of AEs, 14
(28.0%) studies classified AEs by severity. To determine the total number of nonserious and
severe AEs across all studies, we used a modified operational definition of severity of AEs by
Vincent et al,29 and found 286 (96.3%) nonserious AEs and 11 (3.7%) serious AEs reported in

N

these studies (Suppl. Appendix 3).

U

[H2] Reporting of Dropouts
One hundred three studies (91.2%) included a clear statement regarding DOs. There was

no significant difference in the inclusion of a statement regarding DOs, pre- and post-
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exercise intensity was not specified in 57.9% of the study arms. As there were too few studies

CONSORT-2010 13 (88.4% vs 92.9%; X21 =0.66; p=0.42). Eighty studies (77.7%) reported DOs
occurring during the exercise intervention (Tab. 2). Sixty-one studies (54.0%) reported using an
intention-to-treat approach to analysis (Suppl. Appendix 4). The reasons for subject DOs during

RI
PT

did not like the exercise intervention, time commitment required, and chlorine sensitivity. The

SC

most common reason for dropping out was a musculoskeletal pain. Sixteen studies (15.5%) gave
reasons for DOs that were similar to types of AEs reported in other studies of therapeutic

U

exercise (Tab. 3).

AN

On a subject-level, 39 out of 644 (6.1%) individuals who dropped out, dropped out for
reasons that could be considered exercise-related AEs, yielding 336 patients (6.0%) experiencing

M

exercise-related AEs. None of the 39 reclassified DOs could be considered severe AEs. There

D

was a significant difference in misclassification of DOs pre- and post-CONSORT-201013 (12.2%

TE

vs. 3.1%; X21=21.2; p<.00001), wherein studies published prior to the statement had more

EC

misclassification of DOs than those published after the statement.

CO
RR

[H2] Association between Therapeutic Exercise and Severity of Adverse Events
Due to study heterogeneity with respect to exercise program attributes or lack of

specificity of exercise program data, it was not possible to conduct a meta-analysis. However,
among the 105 exercise arms with complete information regarding exposure time there were 248

N

episodes of exercise-related harm. The incidence rate (IR) and 95% confidence interval (95%

U

CIs) per 100,000 exercise hours for non-serious AEs/DOs (n = 237) was 105.6 (101.1-110.3).
For severe AEs/DOs (n = 11), the incidence rate was 4.9 (4.0 – 6.0) per 100,000 exercise hours.
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the intervention period included: heart problems, neck and back pain, leg and knee pain, patient

Regardless of severity, the incidence rate for all AEs/DOs was 110.5 (105.9-115.3) per 100,000
exercise hours.

RI
PT

We found 44.2% of the 113 randomized controlled trials across the 40-year period

SC

included a statement regarding AEs. This result is similar to data in another systematic review by
Quicke et al. examining 49 studies of physical activity interventions among adults 45 and older

U

with knee pain, and reported 45% of studies included information about AEs.22 Ethgen et al

AN

examined harm reporting in pharmacologic and non-pharmacologic studies for the management
of rheumatic disease including exercise for OA, and found 47.3% of nonpharmacologic studies

M

included a statement of AEs.18 These data are concerning and suggest adherence to CONSORT

D

reporting guidelines is poor in studies of exercise for OA. There is a possibility that researchers

TE

examining therapeutic exercise for OA management believe that it is safe and focus less on the
of reporting intervention-related harm compared to researchers engaged in drug trials

EC

studies18,32,33 or spinal manipulation34 where transient discomfort can be experienced

CO
RR

immediately following the procedure, though serious AEs associated with its use have not been
identified. Additionally, unlike pharmacologic interventions which have strict regulatory
guidelines for testing, therapeutic exercise is not held to that same level of scrutiny.18, 32, 33 This
low prevalence of AE statements suggests that harm reporting in clinical trials of therapeutic

N

exercise may receive less attention than issues related to internal consistency and study efficacy.

U

While some transient musculoskeletal sequelae can be expected beginning an exercise program,
it is important to inform patients that transient discomfort may be expected to reduce their fears
and decrease the impact of fear avoidance behaviors. But, if musculoskeletal pain is significant

Downloaded from https://academic.oup.com/ptj/advance-article/doi/10.1093/ptj/pzab161/6310001 by Chapman University user on 02 July 2021

[H1] Discussion

enough to lead patients to discontinue exercise and drop out of the study, then we propose that
reason for dropping out should also be considered an AE.
The CONSORT harm statement requires researchers to classify the severity of AEs.17 We

RI
PT

This low rate of adherence to the CONSORT harm statement is similar to rates reported in other

SC

studies of nonpharmacologic interventions in arthritis.18, 22 For example, Ethgen et al. found

16.2% of nonpharmacologic studies classified AEs by severity, a rate 5 times lower than the rate

U

for pharmacologic interventions in arthritis.18 In this review, we classified all AEs and found 11

AN

(3.7%) serious AEs. Thus, specific attention to reporting severity of AEs in clinical trials of
therapeutic exercise in knee OA is warranted.

M

Given that exercise requires active participation of patients over an extended period of

D

time and adherence rates are known to be low, researchers often utilize intention-to-treat analysis

TE

to account for DOs. Thus, we found a much higher rate (91.2%) of DO statements, and there was
no statistically significant difference in these statements pre-and post-CONSORT-2010.13

EC

However, among the 16 studies that reported DOs, the intervention-related reasons for dropping

CO
RR

out were reported as AEs in other studies. These data support the hypothesis that there is no
consistency regarding DO classification across studies of therapeutic exercise, leading to a
potential for greater exercise-related harm than currently reported. To enhance the credibility of
studies of therapeutic exercise in KOA, it is important for authors to report operational

N

definitions of AEs and DOs within their methods. Additionally, many studies did not report the

U

exact timing of DOs across the study timeframe. We agree the CONSORT Harms Statement17 is
the gold standard for reporting of harms in randomized controlled trials. Based on the results of
this systematic review, we provide additional recommendations for documenting exercise
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found 14 of the 50 studies which included a statement about AEs, classified AEs by severity.

interventions and reporting the number of DOs and AEs at each time point. We emphasize that it
is important to clarify whether an AE led to a patient dropping out of the study. Finally, as knee
pain is a symptom of KOA, it is important be able to determine whether knee pain experienced

RI
PT

2).

We also aimed to determine whether AEs and DOs were classified differently in studies

SC

published prior to versus after the CONSORT-2010 statement.13 We were able support our

U

hypothesis that reporting of AEs was affected by the CONORT statement, as there was a

AN

statistically significant difference in inclusion of statements regarding AEs pre- and post its
publication. Thus, CONSORT has improved the manner in which RCTs are reported and these

M

positive impacts can only help to improve our ability to evaluate the evidence for therapeutic

D

exercise in the management of knee OA.

TE

There is agreement across health professionals that therapeutic exercise, while providing
benefits, presents greater than minimal risk (eg, may cause fatigue or musculoskeletal pain

EC

beyond what would normally be experienced by the subjects in daily activities).35

CO
RR

Therapeutic exercise should be prescribed to patients in the same manner as medications and
along with clear instructions to ensure therapeutic exercises are performed in the correct manner
(ie, dose, frequency, intensity, mode, and supervision).21 Within these studies, therapeutic
exercise interventions were not fully described. Researchers consistently reported the frequency

N

of exercise per week and total length of the exercise program. Not surprisingly, the most

U

common frequency utilized was three times per week, as this is often considered the minimal
frequency for obtaining benefits from exercise.20, 21 However, the duration of individual sessions
was difficult to discern in many cases, especially when exercises were prescribed as a number of

Downloaded from https://academic.oup.com/ptj/advance-article/doi/10.1093/ptj/pzab161/6310001 by Chapman University user on 02 July 2021

during a study intervention reaches a threshold that qualifies it for being defined a “harm” (Fig.

repetitions for a series of exercises. This limited our ability to synthesize the data from these
studies with other studies that provided the duration of the exercise session. There were also
many different modes of exercise and combinations of modes of exercise, making it difficult to

RI
PT

Interestingly, we found assessment of exercise intensity was not reported in 57.9% of the

exercise programs used in these clinical trials, despite the fact it is common knowledge that

SC

intensity of exercise has been associated with risk of harm.36 It is important to include all

U

dimensions of therapeutic exercise and identify which subgroups of patients benefit the most

AN

from various therapeutic exercise prescriptions.37 It was beyond the scope of this article to try to
determine which type of therapeutic exercise is less harmful for these patients. We did attempt to

D

exercise programs and found the rate was low.

M

ascertain the incidence rate of severe and non-serious AEs among these studies of therapeutic

TE

[H1] Limitations and Strengths

There exists a risk for misclassification bias of study-reported AEs reported, as each

EC

research team used their own AEs definition. Additionally, our reclassification of DOs as AEs

CO
RR

may be at risk for misclassification bias as the details regarding DOs were vague. However, we
used a standardized approach to categorize the reasons for DOs and a published definition of
AEs.29 While we did not assess inter-rater reliability for coding of study elements, the research
team a priori developed and used a standardized protocol for data extraction and conducted data

N

extraction separately before coming to a consensus regarding coding. As we included only

U

studies published in English, we may not be including all relevant studies. To examine AEs and
DOs by exercise dose, we calculated incidence ratios, combining modes of exercise and
calculating the summative exposure. However, data were limited regarding exercise attributes
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discern what types of exercise may be less harmful in specific subgroups of patients.

and many studies used mixed modes of exercise, which prevented subgroup analysis of AEs and
DOs by mode of exercise.
With respect to study strengths, only randomized controlled trials of therapeutic exercise

RI
PT

occurred, was attributed only to therapeutic exercise. We also used a universally accepted

SC

method, PEDro,27 for scoring study quality. The search was repeated a second time prior to data
extraction to confirm the accuracy of the included studies. Data were extracted regarding all

U

aspects of the therapeutic exercise interventions in order to determine the association between

AN

exercise attributes and potential harm. However, the level of missing data regarding interventions

the studies a meta-analysis could not be performed.

D

[H1] Conclusions

M

prohibited an evaluation of exercise dose and potential harm. Finally, due to the heterogeneity of

TE

While evidence suggests that therapeutic exercise is a safe treatment option for managing
knee OA symptoms,1-3 there is room for improvement in the reporting of AEs and DOs in trials

EC

of therapeutic exercise. AEs and DOs may be underreported and not sufficiently represent the

CO
RR

risk associated with therapeutic exercise for knee OA. Greater clarity regarding AE definitions
and adherence to the CONSORT harm statement17 is needed to best determine safe dosing of
therapeutic exercise for knee OA. Exercise intensity is frequently not specified in randomized
controlled trials of therapeutic exercise and the duration of the individual exercise sessions is

N

often missing. Greater details regarding the interventions must be included in published papers to

U

ensure proper implementation of exercises for the treatment of knee OA. We recommend
establishing an operational definition of AEs and DOs for therapeutic exercise trials and that
researchers use the TIDier,9 CONSORT statements,13, 17 and CERT38 to describe their
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without concurrent inclusion of modalities or medications were included to ensure harm, when it

interventions details and record AEs and DOs. Results of this paper can be used to inform the
design and reporting of trials of therapeutic exercise.
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Figure 1: PRISMA flow diagram of randomized studies of therapeutic exercise for KOA.
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PT
SC
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M
D
TE
EC
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exercise for knee osteoarthritis to complement the CONSORT harms statement. KOA = Knee
osteoarthritis

N

Table 1: Attributes of Therapeutic Exercise Interventions (N = 152) in Randomized Controlled

U

Trials of Exercise for Adults (N = 5909) With Knee Osteoarthritisa
Category

Total Weeks of Exercise Training

No. of Study Arms (%)

No. of Exercisers (%)
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Figure 2: Additional recommendations for reporting of harm in clinical trials of therapeutic

30 (0.5)

< 6 weeks

20 (13.2)

682 (11.5)

≥ 6 weeks and <12 weeks

50 (32.9)

1406 (23.8)

12 weeks

48 (31.6)

2110 (35.7)

> 12 weeks to < 52 weeks

27 (17.8)

1145 (19.4)

≥ 52 weeks

6 (3.9)

536 (9.1)

RI
PT

1 (0.7)

52 (34.2)

3x/week

80 (52.6)

4-5x/week

11 (7.2)

> 5x/week

3 (2.0)

D

Duration of individual exercise sessions

43 (28.3)

< 30 minutes

TE

Unspecified

1899 (32.1)

U

1-2x/week

147 (2.5)

AN

6 (3.9)

M

Unspecified

SC

Frequency per week

3255 (55.1)
511 (8.7)
97 (1.6)

1393 (23.6)

14 (9.2)

695 (11.8)

41 (27.0)

1430 (24.2)

52 (34.2)

2098 (35.5)

2 (1.3)

293 (4.9)

Yes, partial

40 (26.3)

1796 (30.4)

Yes

112 (73.7)

4113 (69.6)

Unspecified

2 (1.3)

116 (1.9)

Strengthening (progressive or not)

46 (30.3)

1534 (26.0)

Aerobic (including walking)

7 (4.6)

148 (2.5)

> 45 to ≤ 60 minutes

CO
RR

> 60 minutes

EC

≥ 30 minutes to ≤45 minutes

Supervised sessions

U

N

Modes of exercise
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Unspecified

9 (5.9)

260 (4.4)

Tai chi, yoga and other non-traditional exercise

18 (11.8)

551 (9.3)

Any combined aerobic, flexibility, ROM,

26 (17.1)

1342 (22.7)

Aquatic or aquatic and land exercises

15 (9.9)

539 (9.1)

Combined balance, ROM, flexibility,

27 (17.8)

1249 (21.1)

RI
PT

strengthening

Physical therapy plus all modes of exercise

SC

strengthening
2 (1.3)

170 (2.9)

Perceived exertion scale

21 (13.8)

% heart rate reserve or maximal heart rate

16 (10.5)

% strength performance test

24 (15.8)

D

597 (10.1)
651 (11.0)
680 (11.5)
165 (2.8)

Some studies had more than one exercise program being tested. ROM = Range of motion

CO
RR

EC

a

3 (2.0)

3816 (64.6)

TE

Not well described

AN

88 (57.9)

M

Unspecified

U

Assessment of Exercise Intensity

Table 2: Summary of Adverse Events and Dropouts Reporting in Clinical Trials of Therapeutic
Exercise (n = 113)a

N

Category

U

Total number of subjects in exercise arm
Studies with a clear statement of AEs
Studies which reported exercise-related AEs occurring among those subjects who were

Number (%)
5909
50 (44)
24 (21.2)
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Balance and neuromuscular training

allocated to exercise
Studies which reported exercisers experiencing an AE NOT related to exercise (among

5 (12.5)

those with statement about AEs)

Number of exercisers who had an exercise-related AE in exercise study arms that had
a clear statement about AEs

297 (10.4)

58 (2.0)

SC

Number of exercisers who had an AE NOT related to exercise in studies that had a

RI
PT

2856

clear statement about AEs

U

Studies with a clear statement of DOs

103 (91.2)
76 (73.9)

Studies in which reasons for DOs could be considered AEs (eg, back pain, knee pain,

16 (15.5)

AN

Studies which reported DOs among studies which had a clear statement of DOs

M

neck pain, leg pain, wrist pain) among all studies which had a statement of DOs

D

Total number of exercisers in studies which had a clear statement of DOs

TE

Number of exercisers who DO out where DO reason could be considered an AE

5562
39 (0.7)

among all exercisers in studies which reported DOs

EC

Number of exercisers who DO out where DO reason was not considered harm
Total number of exercisers in studies that had a statement of AEs or a statement about

CO
RR

DOs

605 (10.9)
5579

Number of exercisers who DO out where reasons for DO could be interpreted as an
exercise-related AE plus

N

total number of exercise-related AEs reported

AE = Adverse Event; DO = Dropout.

U

a

336 (6.0)
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Total number of exercisers in studies which had a clear statement of AEs

Table 3: Comparison Between Types of Adverse Events and Reasons for Dropping Out of
Studies Among Patients Who Exercised
Reasons for Dropout Which

Reported

Study That Are Similar to

Are Not Similar to Adverse

Reported Adverse Events

Events

Back pain

Back pain

Did not like type of exercise

Hip pain

Knee pain

Bad general health

Leg pain

Neck pain

Required joint injection

Falls/Fractures

Leg pain

Chlorine sensitivity

Knee pain

Wrist pain

SC

U

AN

Unable to attend sessions
NSAID taken after allocation

M

Muscle strain/soreness
Swollen knees

D

Varices

Osteoarthritis flare/pain

N

CO
RR

EC

Injury during strength training

TE

Dizziness

U

RI
PT

Reasons for Dropping Out of

Heart problems
Discontinued intervention- no
reason
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Types of Adverse Events

